[补充材料]CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

发表于 1 小时前

期刊：Cancer Letters

文献作者：Feifan Yao; Suiqing Zhou; Ruizhi Zhang; Yining Chen; Wei Huang; Kai Yu; Nanmu Yang; Xiangjun Qian; Xiaofeng Tie; Jiali Xu; Yu Zhang; Tasiken Baheti; Jing Xu; Xinzheng Dai; Xiaopei Hao; Liren Zhang; Xuehao Wang; Qing Li

出版日期：2024-7-

DOI号：10.1016/j.canlet.2024.216935

下载链接：https://www.sciencedirect.com/sc ... 304383524003288/pdf

文献链接：https://doi.org/10.1016/j.canlet.2024.216935

当前文献来源于 Elsevier BV。

备注信息：补充材料！！！！！！！！！！！！！！补充材料！！！！！！！！！！Appendix A. Supplementary data！！！！！！！

发表于 1 小时前

: 当前求助处于待确认状态,请尽快下载
如果48小时后该求助仍未采纳，系统将自动采纳。

[Elsevier/Sciencedirect] [补充材料]CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] [补充材料]CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma 一键复制

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] [补充材料]CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma